• Home
  • NEW DAY MEDICINE
  • 3 (31) 2020
  • 39 -3 (31/1) 2020 — Shodiev B.V., Rasul-Zade Y.G. — OPTIMIZATION OF PREPARATION FOR ASSISTED REPRODUCTIVE TECHNOLOGIES AND PREGNANCY OUTCOME IN WOMEN WITH TUBOPERITONEAL INFERTILITY

39 -3 (31/1) 2020 — Shodiev B.V., Rasul-Zade Y.G. — OPTIMIZATION OF PREPARATION FOR ASSISTED REPRODUCTIVE TECHNOLOGIES AND PREGNANCY OUTCOME IN WOMEN WITH TUBOPERITONEAL INFERTILITY

OPTIMIZATION OF PREPARATION FOR ASSISTED REPRODUCTIVE TECHNOLOGIES AND PREGNANCY OUTCOME IN WOMEN WITH TUBOPERITONEAL INFERTILITY

Shodiev B.V. -Bukhara State Medical Institute named after Abu Ali ibn Sino, Uzbekistan.

Rasul-Zade Y.G. -Bukhara State Medical Institute named after Abu Ali ibn Sino, Uzbekistan.

Resume

Tubal infertility is one of the main indications for in vitro fertilization (IVF). The cause of tubal infertility is also an important factor in IVF outcomes. In these cases, many factors influence IVF success, including the patient’s age, the quality of ovarian stimulation, the quality and number of embryos transferred, and the appearance of the endometrial using ultrasound. Lack of proconceptional preparation has been associated with significantly higher reproductive risks, ranging from infertility to intrauterine structural defects and long-term illness. In this review, we focus on the reproductive risks associated with certain periconceptual supports, a critical step in determining fetal development and health due to the potential onset of a number of diseases in women with tubal infertility.

Key words: tubal-peritoneal infertility, in vitro fertilization, proconceptional preparation, folic acid, homocysteine.

First page

173

Last page

176

For citation: Shodiev B.V., Rasul-Zade Y.G., Optimization of preparation for assisted reproductive technologies and pregnancy outcome in women with tuboperitoneal infertility//New Day in Medicine 3(31)2020 173-176 https://cutt.ly/3xIcxXn

List of References

  1. Boivin J, Bunting L, Collins JA, Nygren KG. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod. 2007;22(6):1506- 12
  2. Inhorn M, P.P. Infertility around the globe: new thinking on gender, reproductive technologies, and global movement in the 21st century. Human Reproductive Update. 2015;21(4):411-26.
  3. Cousineau TMD, Alice D. Psychological impact of infertility. Clin Obstet Gynecol. 2006;21(2):293-308.
  4. Daar AS, Merali Z. Infertility and social suffering: the case of ART in developing countries. Current practices and controversies in assisted reproduction. 2002:15-21.
  5. Quaas A, Dokras A. Diagnosis and Treatment of Unexplained Infertility. Rev Obstet Gynecol. 2008;1(2):69-76.
  6. Bayer SR, Alper MM, Penzias AS. Handbook of infertility, 2nd ed, 2007, Boston, Informa Healthcare, 1-259.
  7. Schlegel PN, Fauser BC, Carrel DT, Racowsky C. Biennial review of infertility, 2013, London, Springer, 1-264.
  8. G.M. Honor?, A.E. Holden, R S SchenkenPathophysiology and management of proximal tubal blockage //Review// FertilSteril 1999 May; 71(5):785-95.doi: 10.1016/s0015-0282(99)00014-x.
  9. Shalev J, Krissi H, Blankstein J, Meizner I, Ben-Rafael Z, Dicker D. Modified hysterosalpingography during infertility work­up: use of contrast medium and saline to investigate mechanical factors. FertilSteril 2000; 74: 372-75. doi: 10.1016/S0015- 0282(00)00632-4
  10. Jansen FW, Kapiteyn K, Trimbos-Kemper T, Hermans J, Trimbos JB. Complications of laparoscopy: a prospective multicentre observational study. Br J ObstetGynaecol 1997; 104: 595-600. doi: 10.1111/j.1471-0528.1997.tb11539.x
  11. Panchal S, Nagori C. Imaging techniques for assessment of tubal status. J Hum Reprod Sci 2014; 7: 2-12. doi: 10.4103/0974­1208.130797
  12. US Department of Health and Human Services 2004 Assisted Reproductive Technology Success Rates: National summary and Fertility Clinic Reports. 2006
  13. Westrom L. Effect of pelvic inflammatory disease on fertility. Venereology: official publication of the National Venereology Council of Australia. 1995;8(4):219-22.
  14. Wiesenfeld HC, Hillier SL, Meyn LA, Amortegui AJ, Sweet RL. Subclinical pelvic inflammatory disease and infertility. Obstet Gynecol. 2012;120(1):37-43.
  15. Shodiev B.V. Ikhtiyarova G.A., KurbanovaZ.Sh., Rozikova D.K., Diagnostics and preparation of women with low ovarian reserve of ovaries for assisted reproductive technologies // F: New day in medicine №2 (30) 2020
  16. F. Mitri, A. D. Andronikou, and S. Perpinial, “A clinical comparison of sonographic hydropertubation and hysterosalpingography,” International Journal of Obstetrics &Gynaecology, vol. 48, pp. 1031-1036, 1991.
  17. D. E. Luciano, C. Exacoustos, and A. A. Luciano, “Contrast ultrasonography for tubal patency,” Journal of Minimally Invasive Gynecology, vol. 21, no. 6, pp. 994-998, 2014.
  18. Y. Wang and L. Qian, “Tree- or four-dimensional hysterosalpingo contrast sonography for diagnosing tubal patency in infertile females: a systematic review with meta-analysis,” British Journal of Radiology, vol. 89, Article ID 20151013, 2016.
  19. S. Maheux-Lacroix, A. Boutin, L. Moore et al., “Hysterosalpingosonography for diagnosing tubal occlusion in subfertile women: A systematic review with meta-analysis,” Human Reproduction, vol. 29, no. 5, pp. 953-963, 2014.
  20. Khanum S, Ahmed J, Rahim M, Sultana N, Begum R. Evidence Based Diagnostic Approach to Tubal Factor Infertility. BIRDEM Med J. 2014;4(1):33-7.
39-173-176-3-31-2020-

file

download